Pro-resolving lipid mediator Resolvin D1 reduces inflammation and promotes lesion regression by targeting cell death pathways in atherosclerosis

促溶解脂质介质 Resolvin D1 通过靶向动脉粥样硬化中的细胞死亡途径来减少炎症并促进病变消退

• 批准号: 400533
• 负责人: Duchez Anne-Claire
• 金额: $ 0.07万
• 依托单位: Ottawa Heart Institute Research Corporation (Ontario)
• 依托单位国家: 加拿大
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-01-01 至 2020-01-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=400533&lang=en
• 关键词: Ics Travel Awards

Cardiovascular disease (CVD) are the leading cause of illness and death in the world. Atherosclerosis is one them and is responsible of one fifth of death in Canada. Atherosclerosis affect blood vessel (arteries) that carry fresh oxygen rich blood from th

心血管疾病(CVD)是世界上导致疾病和死亡的主要原因。动脉粥样硬化就是其中之一，在加拿大五分之一的死亡是由动脉粥样硬化造成的。动脉粥样硬化影响从动脉输送新鲜富氧血液的血管(动脉)